Search

Erasca Inc

Chiusa

14.21 0.85

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

13.79

Massimo

14.41

Metriche Chiave

By Trading Economics

Entrata

139M

-44M

EPS

-0.14

Dipendenti

103

EBITDA

139M

-43M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+69.3% upside

Dividendi

By Acuity

Utili prossimi

10 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1B

5.3B

Apertura precedente

13.36

Chiusura precedente

14.21

Erasca Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

28 set 2026, 23:56 UTC

Scotts Miracle-Gro Co is down in after-market hours, marking a fifth consecutive session of lower performance and remaining below its 20-day moving average.

28 set 2026, 23:56 UTC

Correlated Moves

BILL Holdings Inc trades modestly higher in after-market hours, supported by positive momentum in Gen Digital Inc following optimistic comments on its fiscal 2027 outlook.

28 set 2026, 23:56 UTC

Correlated Moves

Pinnacle West Capital Corp traded modestly higher in after-market hours, maintaining a steady return since Monday's close, despite broader market conditions.

28 set 2026, 23:56 UTC

Patterson-UTI Energy Inc is gaining modestly in after-market trading, continuing a routine move since Monday's close while remaining below its 20-day moving average.

28 set 2026, 23:55 UTC

Gray Media Inc has advanced modestly in after-market trading, reflecting a shift in momentum despite remaining below its 20-day moving average.

28 set 2026, 23:55 UTC

Voya Financial Inc is trading lower in after-market hours, remaining near the low end of its one-month range and below its 20-day moving average.

28 set 2026, 23:55 UTC

Global Net Lease Inc is trading modestly higher in after-market hours, reflecting stronger performance compared to the previous seven sessions that all ended lower.

28 set 2026, 23:55 UTC

News

Neurocrine Biosciences shares rise in after-market trading following the return of Eiry W. Roberts, M.D., as Chief Medical Officer, ensuring continuity for late-stage programs.

28 set 2026, 23:55 UTC

Emerson Electric Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and showing notable upward movement since Monday's close.

28 set 2026, 23:55 UTC

Huntington Bancshares Inc is trading modestly higher in after-market hours, stabilizing above earlier session lows while remaining below its 20-day moving average.

28 set 2026, 23:55 UTC

F5 Inc's shares are trading modestly lower in after-market hours, continuing a downward trend that has persisted for five consecutive sessions.

28 set 2026, 23:55 UTC

Xenon Pharmaceuticals Inc. is trading lower in after-hours, shifting from a slight gain to a more substantial loss since Monday's close, remaining below its 20-day moving average.

28 set 2026, 23:55 UTC

CMS Energy Corp is trading modestly higher in after-market hours, recovering from a low point immediately after the regular session close.

28 set 2026, 23:55 UTC

APA Corp's shares advanced modestly in after-market trading, stabilizing after earlier gains but remaining below the 20-day moving average.

28 set 2026, 23:51 UTC

Novavax Inc. traded modestly higher during after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

28 set 2026, 23:51 UTC

Leonardo DRS Inc is trading modestly higher in after-market hours, rebounding from an earlier session low and showing unusual strength compared to typical patterns.

28 set 2026, 23:51 UTC

News

ACADIA Pharmaceuticals shares declined in after-market hours despite the allowance of a U.S. patent for weight-banded dosing of trofinetide, extending protections until March 2041.

28 set 2026, 23:51 UTC

In after-market trading, MercadoLibre Inc is rising following four sessions of decline, amid significant gains in the Broadline Retail sub-sector.

28 set 2026, 23:51 UTC

Peloton Interactive Inc is declining in after-market trading, hitting its lowest point of the day and remaining below its 20-day moving average.

28 set 2026, 23:51 UTC

EHang Holdings Ltd is rising in after-market trading, gaining ground after five consecutive lower sessions, despite remaining below its 20-day moving average.

28 set 2026, 23:51 UTC

CF Industries Holdings Inc saw a modest decline in after-market trading, remaining near the lower end of its one-month range and below its 20-day moving average.

28 set 2026, 23:51 UTC

Affiliated Managers Group Inc is trading lower in after-market hours, continuing a decline since Monday's close despite earlier gains during the session.

28 set 2026, 23:51 UTC

Qfin Holdings Inc saw a notable rise in after-market trading, advancing sharply following eight consecutive lower daily finishes, though still below its 20-day moving average.

28 set 2026, 23:51 UTC

News

Prospect Capital Corp shares are trading higher in after-market hours following a cash distribution announcement of $0.56232 per share from its fund.

28 set 2026, 23:51 UTC

Block Inc declined in after-market hours, continuing a trend of lower closes amid broader market weakness and trading significantly below its 20-day moving average.

28 set 2026, 23:51 UTC

Australia's Balance of Trade report on October 1 is expected to show a AUD 2.1 billion surplus, reflecting strong resource exports amid cautious market optimism and global inflation concerns.

28 set 2026, 23:51 UTC

JOLTs Job Openings Data Release on September 29 Expected to Show Decline Amid Rising Inflation Fears and Geopolitical Tensions, Influencing Fed Rate Hike Speculations.

28 set 2026, 23:51 UTC

US Initial Jobless Claims Expected at 200K, Indicating Labor Market Resilience Amid Inflation Concerns

28 set 2026, 23:51 UTC

News

Boston Scientific Corp. has secured a contract worth up to $135.7 million from the U.S. Department of Defense, while shares have moved modestly lower in after-market trading.

28 set 2026, 23:51 UTC

Molson Coors Beverage Co's shares traded modestly higher in after-market hours on Monday, despite fluctuations and positioning below the 20-day moving average.

Confronto tra pari

Modifica del prezzo

Erasca Inc Previsione

Obiettivo di Prezzo

By TipRanks

69.3% in crescita

Previsioni per 12 mesi

Media 24.125 USD  69.3%

Alto 33 USD

Basso 20 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Erasca Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

6

Acquista

2

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.